Innospec Inc.’s IOSP shares have gained 18.9% in the past year. The company also outperformed the industry’s fall of 13.5%. Zacks Investment Research Image Source: Zacks Investment Research Let’s take a look at the factors driving the stock’s price appreciation. Strategic Expansion and QGP Acquisition Fuel Optimism Innospec, carrying a Zacks Rank #3 (Hold), is capitalizing on its robust Performance Chemicals segment and strategic growth initiatives. The company is dedicated to advancing technology development and enhancing margins to drive organic growth across its diverse business portfolio. In the first quarter, Innospec reported adjusted earnings per share of $1.75, up from $1.38 in the previous year and surpassing the Zacks Consensus Estimate of $1.64. Although revenues saw a 2% decline to $500.2 million from prior-year levels and missed the Zacks Consensus Estimate of $508 million, the Performance Chemicals segment showed consistently strong performance. The segment's operating income more than doubled year over year, driven by increased sales and improved gross margins. The acquisition of QGP Quimica Geral in Brazil expands Innospec’s global footprint and manufacturing capabilities, enhancing customer service in South America. QGP's specialty chemistry expertise, particularly in growth markets like Agriculture, complements Innospec's existing portfolio. This acquisition aligns with Innospec's M&A strategy, bolstering the Performance Chemicals segment and establishing a manufacturing base in South America. Innospec emphasized its debt-free balance sheet following the takeover, positioning the company well for future M&A activities, shareholder returns and strategic organic growth investments. During its first-quarter call, Innospec highlighted a broad array of technology-driven organic opportunities across its business segments. These factors are expected to continue driving growth and margin improvement. With significant flexibility and balance sheet strength, Innospec is well-positioned for potential dividend growth, stock buybacks, mergers and acquisitions and further organic investments. Stocks to Consider Some better-ranked stocks in the Basic Materials space are Carpenter Technology Corporation CRS, Eldorado Gold Corporation EGO and Axalta Coating Systems Ltd. AXTA. Carpenter Technology and Eldorado Gold sport a Zacks Rank #1 (Strong Buy), and Axalta carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here. The Zacks Consensus Estimate for CRS’s current-year earnings is pegged at $4.35, indicating a year-over-year rise of 282%. CRS’ earnings beat the Zacks Consensus Estimate in three of the last four quarters while matching it once, the average earnings surprise being 15.1%. The company’s shares have soared 89.2% in the past year. The Zacks Consensus Estimate for EGO’s current-year earnings is pegged at $1.09, indicating a year-over-year rise of 91.2%. EGO’s earnings estimates have gone up 10% in the last 60 days. EGO beat the consensus estimate in each of the last four quarters, the average earnings surprise being 430.7%. The stock has rallied 47.4% in the past year. The Zacks Consensus Estimate for Axalta's current-year earnings is pegged at $1.99, indicating a rise of 26.8% from year-ago levels. AXTA beat the consensus in three of the last four quarters while missing it once, the average earnings surprise being 7%. The stock has rallied nearly 2.8% in the past year. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Carpenter Technology Corporation (CRS):Free Stock Analysis Report Innospec Inc. (IOSP):Free Stock Analysis Report Axalta Coating Systems Ltd. (AXTA):Free Stock Analysis Report Eldorado Gold Corporation (EGO):Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research
Innospec (IOSP) Up 19% in a Year: What's Driving the Stock?
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...